Other languages AccuStem Sciences, Inc.

Equities

ACUT

US00444A1016

Market Closed - OTC Markets Other stock markets 01:25:18 2024-06-03 pm EDT			5-day change	1st Jan Change
0.35 ^USD	-25.52%		+26.35%	-44.06%

May. 20	AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 22	AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 20
AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership	23-07-17
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership	23-07-17
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer	23-07-11
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)	23-06-09
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023	23-06-09
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	23-06-06
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	23-06-06
AccuStem Announce Strategic Clinical and Operational Partnership	23-05-31
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership	23-05-31
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-05-05
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer	23-05-02
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-02-15
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	22-12-06
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	22-11-22
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-11-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages AccuStem Sciences, Inc.

Equities

ACUT

US00444A1016

Other languages

Filters